Jindal Saw Q1: consolidated PAT down 78% YoY to ₹91 Cr as margins collapse; revenue +9%
PAT -78.2% YoY · revenue +9% · margins compressing
₹4,452.31 Cr
+9% YoY
₹90.79 Cr
-78.2% YoY
2.03%
-8.1pp YoY
₹1.63
Jindal Saw's Q1 FY27 confirmed the weak quarter management had flagged on its Q4 call. Consolidated revenue rose 9.0% YoY to ₹4,452.31 Cr (down 3.9% QoQ), but net profit collapsed to ₹90.79 Cr (post-NCI) from ₹415.47 Cr a year ago — a 78.2% YoY fall and 26.6% below the prior quarter's ₹123.68 Cr. Even adjusting for the ₹133.55 Cr prior-year tax refund that inflated the year-ago base, underlying PAT still fell roughly 68%, so the print is genuinely weak, not an optics artefact. Standalone told the same story: revenue ₹3,721.44 Cr (+12.8% YoY) but PAT ₹109.77 Cr versus ₹363.94 Cr YoY (-69.8%). The consolidated figure lagged standalone because overseas subsidiaries posted a net loss of ₹13.11 Cr and the joint ventures swung to a ₹5.37 Cr loss share from a ₹10.39 Cr profit a year ago.
Q1 FY-2027 vs prior quarters
The damage was entirely on margins, not the topline. Operating margin fell to 5.34% from 13.05% a year ago (6.89% in Q4), and net margin to 2.03% from 10.13%. The squeeze sat on cost of materials, which stayed elevated at ₹2,711 Cr even as the prior-year quarter had benefited from a ₹928 Cr inventory build that flattered expenses — this quarter's build was only ₹23 Cr. This matches management's Q4 guidance almost exactly: they warned that suspended MENA shipments and sluggish domestic demand would persist into Q1 and could not confirm margins had bottomed. On that low bar, the company effectively met its own (negative) outlook. No brokerage consensus for the quarter surfaced, so there is no street benchmark to score against.
The stock went into the print at ₹255.2, up 7% over the past month of trading.
Management expects the significant headwinds from Q4, including suspended MENA shipments and sluggish domestic demand, to persist and negatively impact Q1 FY27 results. No quantitative full-year guidance was provided due to the highly unpredictable environment, with management unable to confirm if margins have bottomed
— This quarter: met
Two offsets are worth noting. Finance costs fell to ₹108.43 Cr from ₹171.14 Cr YoY as the balance sheet deleveraged further (consolidated debt-equity 0.29 vs 0.42), consistent with management's stated strategy of funding the Abu Dhabi and Saudi capex from a strong balance sheet. And the API licence reinstatement on June 25 removes an overhang on the oil-&-gas/export pipe order flow — relevant to whether MENA volumes recover in Q2. The JITF ₹1,891 Cr arbitral-award appeal, with judgment reserved at the Delhi High Court, remains a large unquantified swing factor tied to a ₹1,689 Cr investment carrying value.
What to watch
W1
MENA shipment restart: suspended volumes were the flagged headwind; watch Q2 for resumption now that API licences are reinstated (June 25)
W2
Margin bottom: management could not confirm margins had troughed; OPM at 5.34% vs 13.05% YoY — verify sequential recovery in Q2
W3
JITF ₹1,891 Cr arbitral-award appeal: order reserved at Delhi HC divisional bench; outcome affects the ₹1,689 Cr investment carrying value
W4
Abu Dhabi/Saudi capex execution: funded from the deleveraged balance sheet (debt-equity 0.29) — track spend and commissioning timelines
Clean digital PDF; both statements present, consolidated primary. Consol PBT is after JV share -₹5.37 Cr (vs +₹10.39 Cr YoY). Consol PAT ₹90.79 Cr is post-NCI (owners' share ₹104.17 Cr; NCI loss -₹13.39 Cr). Key comparability item: year-ago Q1FY26 tax was a net CREDIT (-₹41.17 Cr consol / -₹63.66 Cr standalone) due to a ₹133.55 Cr prior-year tax refund (note 3), inflating base-quarter PAT; adjusted YoY PAT ~-68%. JITF ₹1,891 Cr arbitral-award appeal order reserved at Delhi HC (note 1).
Informational and educational content only. Not investment advice.